Pharmaceutical Pricing and Reimbursement and the Broader Pharmaceutical Policy Environment

Author：

ISSN： 1608-0203

Source： SourceOECD Industry, Services & Trade, Vol.2008, Iss.12, 2008-09, pp. : 112-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Impact of Pharmaceutical Pricing Policies on Pharmaceutical Innovation

SourceOECD Industry, Services & Trade, Vol. 2008, Iss. 12, 2008-09 ,pp. : 199-230

OECD Publishing

Access to resources Recommend Favorite

Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries

By Balotsky Edward

Journal of Business Ethics, Vol. 84, Iss. 1, 2009-01 ,pp. : 75-88

Springer Publishing Company

Access to resources Recommend Favorite

Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry?

By Hemphill Thomas

Journal of Business Ethics, Vol. 94, Iss. 2, 2010-06 ,pp. : 225-242

Springer Publishing Company

Access to resources Recommend Favorite

The Pharmaceutical Industry and its Activities

SourceOECD Industry, Services & Trade, Vol. 2008, Iss. 12, 2008-09 ,pp. : 66-111

OECD Publishing

Access to resources Recommend Favorite

The Diffusion of a Pharmaceutical Innovation in Ireland

By Ryan J.F. Murray J.A.

European Journal of Marketing, Vol. 11, Iss. 1, 1993-12 ,pp. : 3-12

Emerald Group Publishing Ltd

Access to resources Recommend Favorite